PLUS Diagnostics Announces Senior Executive Ap...(and profitable growth. We have built th...),Health

Date:8/10/2009

and profitable growth. We have built the industry's leading platform for delivering customized diagnostic services that meet the unique needs of the gastroenterology and urology specialties. Our intention is to extend that platform into the hematology and oncology specialties."

Dr. Kamal will focus on leading PLUS Diagnostics' team of pathologists and expanding the company's science technologies. He has expertise across a range of specialties with particular proficiency in gastrointestinal pathology. Dr. Kamal completed his residency at Harbor UCLA Medical Center and his gastrointestinal pathology fellowship training at UCLA. He is frequently asked to lecture at global medical meetings on gastrointestinal pathology and laboratory operations. He is a member of the American Society of Clinical Pathologists and the College of American Pathologists.

Mr. Machulcz will oversee PLUS Diagnostics' California and New Jersey laboratory operations and support staff. During his tenure at Quest Diagnostics, he improved the company's anatomic pathology service levels and productivity, and implemented six sigma projects that contributed to more efficient lab operations. Mr. Machulcz received his bachelor's degree in medical technology from St. Louis University and his master's degree in business administration from Johns Hopkins University.

"We are pleased to have Mark and Mohammad join PLUS Diagnostics," said President and Chief Operating Officer David Pauluzzi. "Their collective years of knowledge and experience will add another level of expertise to our strong management team. Together we will expand our capabilities to offer the most advanced diagnostics available to physicians and the patients they serve."

About PLUS Diagnostics

PLUS Diagnostics is a leading national pathology company that provides a full range of multi-specialty services, including extensive diagnostic proce
'/>"/>

SOURCE PLUS Diagnostics Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
2. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
3. Hypertension Diagnostics Announces Fiscal Year 2007 Results
4. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
5. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
6. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
7. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
8. HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes
9. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
10. Quest Diagnostics Reports Third Quarter Results
11. ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement